Aiganym Tussipova has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Seroprevalence of Anti-Toxocara IgG and Potential Risk Factors Among Adults in Northern Kazakhstan

    by Mukhit B. Orynbayev, Kulyaisan T. Sultankulova, Timur I. Davlyatshin, Aiganym A. Tussipova, Sabyrkhan M. Barmak, Asylzhan A. Myrzakhmet, Oralkhan Tusipkanuly, Dulat A. Inkarbekov, Timur T. Davlyatshin, Sandugash E. Mukazhanova, et al.

    Human toxocariasis is a globally distributed zoonosis caused by nematodes of the genus Toxocara, yet epidemiological data from Kazakhstan remain scarce. This study aimed to estimate the seroprevalence of anti-Toxocara antibodies and to assess potential risk factors among adults in northern Kazakhstan. A cross-sectional seroepidemiological study enrolled 1000 adult residents of the Pavlodar and North Kazakhstan regions (500 per region). Serum samples were tested for IgG antibodies against Toxocara spp. by ELISA and Western blot. Antibodies were detected by ELISA in 102 (10.2%; 95% CI: 8.5–12.2%) and by Western blot in 93 (9.3%; 95% CI: 7.7–11.3%) of the 1000 participants. Agreement between ELISA and WB was 99.1% (Cohen’s κ = 0.949; 95% CI: 0.916–0.982; p < 0.001). Seroprevalence was 10.0% (50/500) in Pavlodar and 8.6% (43/500) in North Kazakhstan (p = 0.514; OR = 1.18; 95% CI: 0.77–1.81). Univariate analysis revealed no statistically significant association between seropositivity and age, sex, place of residence (urban/rural), or any of the potential risk factors examined. These findings indicate exposure of the population of northern Kazakhstan to Toxocara spp. and support the use of two methods (ELISA and WB) in seroepidemiological surveys. Studies with broader geographic coverage are warranted.

  • Open Access

    Anti-Ascaris IgG Seroprevalence and ELISA Performance Among Adults in Three Regions of Kazakhstan

    by Berik M. Khairullin, Mukhit B. Orynbayev, Timur I. Davlyatshin, Kulyaisan T. Sultankulova, Aiganym A. Tussipova, Sabyrkhan M. Barmak, Asylzhan A. Myrzakhmet, Oralkhan Tusipkanuly, Dulat A. Inkarbekov, Timur T. Davlyatshin, et al.

    Regional surveys can help characterize adult exposure to Ascaris and assess the interpretation of different laboratory markers. This cross-sectional study examined 2001 volunteers from the Akmola, Pavlodar, and North Kazakhstan Regions during 2025–2026. Questionnaire data were collected, and paired serum and stool specimens were tested using the MVA GROUP IgG ELISA and Kato–Katz method. Associations with seropositivity were evaluated using multivariable logistic regression, and 300 selected sera were compared with the DRG Ascaris IgG ELISA. Overall seroprevalence was 28.0% (95% CI: 26.1–30.0%), with regional differences remaining after adjustment for age, sex, residence, and sampling year. Kato–Katz positivity was 8.4%, without a significant regional difference. ELISA sensitivity and specificity relative to Kato–Katz were 85.2% and 77.2%, respectively. Agreement with DRG was 95.0% (κ = 0.900). These findings support further regional assessment of adult exposure. Agreement between ELISAs supports consistent antibody classification in the selected panel, while discordance with Kato–Katz requires separate interpretation of antibody detection and intestinal egg shedding.

  • Open Access

    Development of a Species-Specific qPCR Assay for Theileria annulata Detection and Its Molecular Surveillance in Kazakhstan

    by Asylzhan Myrzakhmet, Sabyrkhan Barmak, Kulyaisan Sultankulova, Aidar Namet, Aiganym Tussipova, Timur Davlyatshin, Dulat Inkarbekov, Oralkhan Tusipkanuly, Berik Khairullin, Bekzhassar Sidikhov, et al.

    Theileria annulata causes tropical theileriosis in cattle and is endemic in Kazakhstan. Although molecular diagnostic methods for this pathogen exist, data on its molecular surveillance and genetic diversity in Kazakhstan remain limited. This study aimed to develop and experimentally validate a species-specific real-time PCR (qPCR) assay for the detection of Theileria annulata and to conduct molecular surveillance and phylogenetic analysis of circulating isolates. A total of 709 cattle blood samples from 10 regions of Kazakhstan were analysed. Species-specific primers and a probe were designed targeting the 18S rRNA gene, and diagnostic performance was evaluated against sequencing as the reference method. Theileria annulata infection was confirmed in 110 of 709 samples (15.51%), with positive samples identified in the Turkistan, West Kazakhstan, Kyzylorda, and Zhambyl regions. The developed assay showed high diagnostic sensitivity (99.09%), specificity (99.67%), and diagnostic efficiency (99.58%), with no cross-reactivity with Theileria orientalis, Theileria parva, Babesia bovis, Babesia bigemina, or Anaplasma marginale. Phylogenetic analysis of partial 28S rRNA sequences confirmed the species identity of the detected isolates and demonstrated their close relationship with previously reported Kazakhstani and Chinese isolates. The developed qPCR assay is suitable for the molecular diagnosis and surveillance of bovine tropical theileriosis in Kazakhstan.

  • Open Access

    A Paired-Marker Framework for Interpreting Anti-Ascaris lumbricoides IgG Serology and Copromicroscopy: A Cross-Sectional Study in Almaty and the Almaty Region, Kazakhstan

    by Aidar Namet, Mukhit Orynbayev, Timur Davlyatshin, Kulyaisan Sultankulova, Asylzhan Myrzakhmet, Sabyrkhan Barmak, Dulat Inkarbekov, Oralkhan Tusipkanuly, Aiganym Tussipova, Berik Khairullin

    Background. Stool microscopy and anti-Ascaris IgG serology assess different, but related biological domains. Joint interpretation can identify immunological exposure and intestinal egg shedding without assuming one or both markers are a measure of current infection independently. Objective. To develop a four-pattern paired-marker framework for anti-A. lumbricoides IgG and copromicroscopy results from adults in Kazakhstan and to assess the qualitative analytical concordance of two IgG enzyme-linked immunosorbent assays (ELISAs). Methods. The cross-sectional field study involved 1000 adult volunteers from Almaty and the region providing matched serum and stool samples. Sera were tested by MVA Group indirect anti-Ascaris IgG ELISA, and stool samples were examined by the Kato–Katz and Fülleborn methods. The binary outcome was classified into four pair patterns. All sera were further tested with a commercial ELISA (DRG), and qualitative concordance was calculated. Results. Anti-Ascaris IgG was found in 331 of the 1000 subjects (33.1%; 95% CI, 30.3–36.1%), while A. lumbricoides eggs were detected in 240 subjects (24.0%; 95% CI, 21.5–26.7%). The paired patterns were IgG-positive/egg-positive in 185 participants (18.5%), IgG-positive/egg-negative in 146 (14.6%), IgG-negative/egg-positive in 55 (5.5%), and IgG-negative/egg-negative in 614 (61.4%). IgG positivity was detected in 77.1% of subjects with detected eggs and 19.2% of subjects without detected eggs (odds ratio, 14.15; 95% CI, 9.96–20.09; p < 0.001). The MVA Group and DRG ELISAs agreed for 990 of 1000 specimens (99.0%; 95% CI, 98.2–99.5%), with positive and negative agreements of 98.2% and 99.4%, respectively (κ = 0.98). Conclusions. Serology and copromicroscopy showed a high association, but they are not interchangeable. The paired-marker paradigm clarified concordant and discordant patterns while retaining IgG as a marker of past or ongoing immune exposure and stool eggs as markers of shedding at the time of sampling. High inter-assay agreement suggests analytical consistency within this serum panel, but does not imply diagnostic accuracy for active ascariasis.


  • Open Access

    Human and Canine Seropositivity to Toxocara canis in Uralsk, Kazakhstan: Canine Egg Shedding and Evaluation of an Experimental ELISA

    by Timur Davlyatshin, Aidar Namet, Mukhit Orynbayev, Kulyaisan Sultankulova, Sabyrkhan Barmak, Asylzhan Myrzakhmet, Oralkhan Tusipkanuly, Dulat Inkarbekov, Bayzhan Omarov, Aiganym Tussipova, et al.

    Background: The aim of the present study was to develop and optimize an experimental ELISA test system for the detection of IgG antibodies to Toxocara canis and subsequently apply it for the assessment of human and canine exposure in Uralsk, Kazakhstan, within a One Health framework. Methods: A native somatic antigen of T. canis was fractionated by gel filtration, and the working fraction was selected by SDS-PAGE and pilot ELISA. The optimized test system was used for the analysis of sera of 1000 adult volunteers. Antibody avidity was determined in IgG-positive human specimens, and human seropositivity was evaluated for associations with demographic and questionnaire-derived variables. Serum samples from 100 stray dogs were tested by ELISA and fecal samples by copromicroscopy. Agreement with the commercial DRG ELISA was tested with 50 positive and 50 negative human serum samples. Results: The antigen fraction of 18–22 kDa showed the best separation between positive and negative sera. IgG antibodies against T. canis were detected in 116/1000 volunteers (11.6%). Seropositivity was 17.0% in the 2025 sample and 6.2% in the 2026 sample (odds ratio 3.10; 95% confidence interval 2.01–4.77; p < 0.001). No significant associations were found with sex, age, residence, or questionnaire-derived variables. Among seropositive volunteers, 28.4% had low-avidity, 26.7% intermediate-avidity, 29.3% intermediate/high-avidity and 15.5% high-avidity IgG. Overall, 78/100 of the stray dogs were copropositive, and 93/100 were seropositive. All copropositive dogs were seropositive, and 15 additional seropositive dogs were copronegative. Agreement with the DRG ELISA was 97.0% (Cohen’s κ = 0.94). Conclusions: The experimental ELISA allowed the assessment of T. canis exposure of humans and dogs. Seropositivity in humans in Uralsk showed exposure. High seropositivity in dogs and frequent egg shedding showed a substantial canine reservoir and a potential for environmental contamination. These results support integrated surveillance and control within a One Health context.


  • Open Access

    Susceptibility and Transmission Dynamics of Peste des Petits Ruminants Virus in Domestic and Wild Ruminants: Experimental Insights from Kazakhstan

    by Lespek Kutumbetov, Balzhan Myrzakhmetova, Aiganym Tussipova, Gulzhan Zhapparova, Karina Bissenbayeva, Talshyngul Tlenchiyeva, Sergazy Nurabayev, Aslan Kerimbayev, Mukhit Orynbayev, Edil Makhashov, et al.

    Peste des petits ruminants (PPR) is an extremely contagious viral disease that significantly affects the health of small ruminants and the economies of livestock, particularly in areas adjacent to endemic regions. This study focused on assessing the vulnerability of different domestic and wild animal species in Kazakhstan, which includes local sheep and goats, African Cameroon goats, saigas, calves, and ground squirrels, to infection by the PPR virus (PPRV). Experimental infections used a virulent strain of PPRV (Nigeria 76/1), with animals being monitored over a period of 21–28 days to evaluate clinical signs, pathological lesions, and viral dissemination. The manifestation of disease differed across species, breed, and age. In Cameroon, goats and saigas displayed severe illness with a mortality rate of 100% and elevated virus levels in key organs, whereas local sheep and goats presented age-related subacute, abortive, and latent manifestations. Calves exhibited mild, subclinical infections, while ground squirrels showed no susceptibility. Viral shedding was observed in the secretions of infected animals, with transmission occurring through airborne and alimentary pathways. No virus carriage was detected in the animals that had recovered. The investigation emphasizes the notable variations in PPRV pathogenesis and transmission risk among different species, highlighting the necessity for focused surveillance and control strategies to avert incursions in PPR-free areas like Kazakhstan.


  • Open Access

    Live Turkey Herpesvirus vaccine against Marek’s Disease: development, stabilization, and immunobiological evaluation

    by L.B. Kutumbetov, B.SH. Myrzakhmetova, A.а. Tussipova, G.A. Zhapparova, T.M. Tlenchiyeva, K.B. Bissenbayeva

    Background and Aim. Marek’s disease (MD) is a highly contagious and economically significant viral infection of poultry, caused by Marek’s disease virus (MDV), an alphaherpesvirus that induces lymphomas, paralysis, and immunosuppression in chickens. Kazakhstan currently lacks a domestically produced MD vaccine, resulting in dependence on imports and logistical challenges. This study aimed to develop and evaluate a national live vaccine against MD using a cloned strain of turkey herpesvirus (HVT, strain AV-0007), with optimized production and preservation technologies. Materials and Methods. The AV-0007 strain was propagated in chicken embryo fibroblast (CEF) cultures using stationary, roller, and suspension cultivation methods. Virus yields were optimized by adjusting MOI, nutrient media, and harvest times. Stabilizing media for cryopreservation and freezedrying were formulated. Experimental vaccine preparations in both forms were assessed for sterility, safety, biological activity, and immunogenicity in one-day old chickens. Virus titers were measured using the focus forming unit (FFU50) method, and immunogenicity was evaluated by virus neutralization tests. Results. Virus titers exceeded 10⁶ FFU50/cm³ across optimized cultivation methods. Cryopreserved and freeze dried vaccines preserved high viral activity after stabilization and storage. Both forms met international standards for sterility and were non-pathogenic in chicks even at 10× immunizing doses. Immunized birds developed virus neutralizing antibodies with titers ranging from 1.67 to 2.33 log FFU50, indicating strong immunogenicity and protective potential. Conclusion. The AV-0007-based vaccine formulations demonstrated safety, stability, and high immunogenicity. The study confirms the feasibility of producing a domestic Marek’s disease vaccine in Kazakhstan and provides a foundation for the local development of poultry vaccines aligned with international quality standards.

  • Open Access

    Advances and challenges in the development of Crimean-Congo Hemorrhagic Fever vaccines: from traditional approaches to modern technologies

    by A.а. Tussipova, B.SH. Myrzakhmetova, G.A. Zhapparova, T.M. Tlenchiyeva, K.B. Bissenbayeva, М. Ramishvili, K.D. Zhugunissov, L.B. Kutumbetov

    Crimean-Congo Hemorrhagic Fever (CCHF) is a high mortality, tick-borne viral illness endemic to Africa, Asia, the Middle East, and certain regions of Europe. Notwithstanding its peril to public health, there is presently no licensed vaccination available. This study highlights important progress and challenges in developing CCHF vaccines, including traditional methods (inactivated and live-attenuated vaccines) and new approaches (subunit, DNA, mRNA, and viral vectors). We also investigate the functions of adjuvants and delivery technologies – such as nanoparticles and viral vectors – in enhancing immunogenicity and safety. Insights from historical endeavors and recent advancements underscore the pressing necessity for safe, effective, and scalable vaccinations, especially in endemic areas. Future initiatives must emphasize cross-protective formulations, thermal stability, and international cooperation.

  • Open Access

    Development and Preclinical Evaluation of a Lyophilized Vaccine Against Equine Herpesvirus Type 4 (EHV-4)

    by Lespek Kutumbetov, Balzhan Myrzakhmetova, Aiganym Tussipova, Gulzhan Zhapparova, Talshyn Tlenchiyeva, Karina Bissenbayeva, Sergazy Nurabayev, Aslan Kerimbayev

    Background/Objectives: Equine rhinopneumonia, caused by equine herpesvirus types 1 and 4 (EHV-1 and EHV-4), continues to be a significant health and economic concern in the global equine industry, particularly in Kazakhstan. While vaccines targeting EHV-1 are available, there is currently no licensed monovalent vaccine for EHV-4, and existing formulations offer limited protection against this serotype. This study aimed to develop and evaluate a freeze-dried, live-attenuated EHV-4 vaccine with improved safety, stability, and immunogenicity. Methods: A field isolate of EHV-4 was attenuated through serial passaging in primary lamb testicle (LT-KK49) cell cultures. Viral biomass was concentrated and formulated with various stabilizers before freeze-drying. The most effective stabilizer composition—sucrose, gelatin, and lactalbumin hydrolysate—was selected based on viral titer retention. Safety and immunogenicity were assessed in mice, guinea pigs, rabbits, donkeys, and horses. A guinea pig reproductive challenge model was used to evaluate protective efficacy. Results: The optimized lyophilized vaccine retained infectivity (>6.0 log10 TCID50/cm3) for at least six months at 4 °C. No adverse clinical signs were observed in any test species. Immunization induced robust neutralizing antibody responses in both small animals and equines. In the guinea pig model, vaccinated females demonstrated 100% pregnancy retention and fetal viability following challenge with a virulent EHV-4 strain. Conclusions: This freeze-dried, live-attenuated EHV-4 vaccine candidate is safe, immunogenic, and thermostable. It offers a promising platform for the targeted prevention of EHV-4 infection, particularly in young horses and in regions with limited cold-chain infrastructure.


  • Open Access

    The immunity and sanitary conditions among people regarding the Covid-19 infection in the post-pandemic period

    by L.B. Kutumbetov, B.SH. Myrzakhmetova, G.A. Zhapparova, T.M. Tlenchiyeva, A.а. Tussipova, K.B. Bissenbayeva, М. Ramishvili

    Background and Aim. A year after the official declaration of the end of the pandemic, this study aimed to assess the epidemic situation by testing a small group of individuals for the presence of the SARS-CoV-2 virus and neutralizing antibodies. Materials and Methods. Nasopharyngeal swabs were collected to isolate SARS-CoV-2 virus in cell culture, while venous blood samples were tested for neutralizing antibodies using a quantitative neutralization reaction. The study included 20 participants (approximately 10% of the team), of whom 16 had been vaccinated against COVID-19, and 4 remained unvaccinated. Vaccinated individuals included 4 who received Sputnik V (over 30 months prior) and 12 who received QazCOVID-in. Results. All 20 participants demonstrated neutralizing antibodies against the Wuhan variant of the virus. For the Delta and Omicron variants, 19 participants showed neutralizing antibodies. Average antibody titers were 6.4 ± 1.39 log₂ for the Wuhan variant, 6.2 ± 1.89 log₂ for the Delta variant, and 4.75 ± 1.84 log₂ for the Omicron variant. Conclusion. The study highlights the persistence of antibodies against SARS-CoV-2 among both vaccinated and unvaccinated participants, though variation in neutralization efficacy was observed among different virus variants. These findings emphasize the importance of monitoring immune responses to track population-level immunity and guide future vaccination strategies.